Abstract P085 – Table 1. Characteristics of 359 experienced people living with HIV that started treatment with 3TC/DTG (265) or RPV/DTG (94). | ||||
---|---|---|---|---|
Variables | 3TC/DTG (n = 265) | RPV/DTG (n = 94) | Overall (n = 359) | p‐value |
Age, mean (±SD) | 50.31±11.76 | 52.18±11.6 | 50.80±11.73 | 0.1835 |
Female gender, n (%) | 53 (20.0) | 29 (30.1) | 82 (22.8) | 0.0313 |
Caucasian ethnicity, n (%) | 245 (92.5) | 84 (89.4) | 329 (91.6) | 0.3521 |
Other ethnicity, n (%) | 20 (7.5) | 10 (10.6) | 30 (8.4) | 0.3521 |
Risk factor | 0.0209 | |||
Sexual, n (%) | 219 (82.6) | 67 (71.3) | 286 (79.7) | |
IDU, n (%) | 25 (9.4) | 19 (20.2) | 44 (12.3) | |
HIV‐RNA detectable at baseline, n (%) | 253 (95.5) | 89 (94.7) | 342 (95.3) | 0.7564 |
HIV‐RNA undetectable at baseline, n (%) | 12 (4.5) | 5 (5.3) | 17 (4.7) | 0.7564 |
Previous regimens, n (%) | ||||
PI | 92 (34.7) | 32 (34.0) | 124 (34.5) | 0.906 |
NNRTI | 75 (28.3) | 46 (48.9) | 121 (33.7) | 0.0003 |
INSTI | 80 (30.2) | 22 (23.4) | 102 (28.4) | 0.2102 |
Anni ART, mean (±SD) | 9.9 (5.4 to 14.9) | 13.2 (7.1 to 20.6) | 10.4 (5.8 to 16.8) | 0.0015 |
CD4 cells/mmc, mean (±SD) | 781.4 (359.8) | 720.7 (304.2) | 765 (346.2) | 0.1469 |
CD4/CD8 ratio, mean (±SD) | 1.09 (0.61) | 0.97 (0.61) | 1.05 (0.61) | 0.1319 |
BMI, mean (±SD) | 25.18 (3.69) | 24.32 (3.84) | 24.92 (3.75) | 0.0744 |